Silvi Luell

1.4k total citations
21 papers, 590 citations indexed

About

Silvi Luell is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Silvi Luell has authored 21 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Silvi Luell's work include Inflammatory mediators and NSAID effects (4 papers), Neuropeptides and Animal Physiology (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Silvi Luell is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Neuropeptides and Animal Physiology (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Silvi Luell collaborates with scholars based in United States, Australia and United Kingdom. Silvi Luell's co-authors include Lloyd J. Old, Edward A. Boyse, Ester Carballo‐Jane, Denise M. Visco, D. Fletcher, D. Euan MacIntyre, Anna Christen, William R. Widmer, Jayne Chin and John L. Humes and has published in prestigious journals such as Nature, Journal of Biological Chemistry and JNCI Journal of the National Cancer Institute.

In The Last Decade

Silvi Luell

21 papers receiving 549 citations

Peers

Countries citing papers authored by Silvi Luell

Since Specialization

Citations

This map shows the geographic impact of Silvi Luell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvi Luell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvi Luell more than expected).

Fields of papers citing papers by Silvi Luell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvi Luell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvi Luell. The network helps show where Silvi Luell may publish in the future.

Co-authorship network of co-authors of Silvi Luell

This figure shows the co-authorship network connecting the top 25 collaborators of Silvi Luell. A scholar is included among the top collaborators of Silvi Luell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvi Luell. Silvi Luell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reconstituted HDL Elicits Marked Changes in Plasma Lipids Following Single-Dose Injection in C57Bl/6 Mice 2011 ·Journal of Cardiovascular Pharmacology and Therapeutics ·Zhu Chen, Edward A. O’Neill, Roger Meurer, Karen Gagen, Silvi Luell, Shengping Wang, Marina Ichetovkin, (unknown), Suzanne S. Eveland, Alison M. Strack, Timothy S. Fisher, Douglas G. Johns, Carl P. Sparrow, Samuel D. Wright, Brian K. Hubbard, Ester Carballo‐Jane	19
2	Anthranilic acid replacements in a niacin receptor agonist 2010 ·Bioorganic & Medicinal Chemistry Letters ·Darby Schmidt, (unknown), Subharekha Raghavan, Hong C. Shen, Fa‐Xiang Ding, Ester Carballo‐Jane, Silvi Luell, (unknown), Tom G. Holt, Michael W. Wolff, Andrew K.P. Taggart, Larissa Wilsie, Mihajlo L. Krsmanovic, Ning Ren, Daniël Blom, Kang Cheng, (unknown), M. Gerard Waters, James R. Tata, Steven L. Colletti	17
3	Altered lipoprotein metabolism in P2Y13 knockout mice 2010 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Daniël Blom, Ting-Ting Yamin, Marie‐France Champy, Mohammed Selloum, Elodie Bedu, Ester Carballo‐Jane, (unknown), Silvi Luell, Roger Meurer, Jayne Chin	38
4	Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) 2009 ·Bioorganic & Medicinal Chemistry Letters ·Songnian Lin, (unknown), (unknown), Jeffrey J. Hale, Sander G. Mills, Kevin T. Chapman, James E. Thompson, (unknown), (unknown), Rose M. Cubbon, Edward A. O’Neill, Silvi Luell, Ester Carballo‐Jane, Lihu Yang	18
5	Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists 2007 ·Journal of Pharmacological and Toxicological Methods ·Ester Carballo‐Jane, (unknown), Silvi Luell, (unknown), Michael W. Wolff, Steven L. Colletti, James R. Tata, Andrew K.P. Taggart, M. Gerard Waters, Jeremy G. Richman, Margaret E. McCann, Michael J. Forrest	13
6	Chemical Genetics Define the Roles of p38α and p38β in Acute and Chronic Inflammation 2007 ·Journal of Biological Chemistry ·Stephen J. O’Keefe, John S. Mudgett, (unknown), Janey N. Parsons, Nicole Chartrain, Catherine E. Fitzgerald, (unknown), (unknown), (unknown), Denise M. Visco, Silvi Luell, Ester Carballo‐Jane, Karen Owens, Dennis M. Zaller	70
7	Potential role for epidermal Langerhans cells in nicotinic acid-induced vasodilatation in the mouse 2007 ·Inflammation Research ·Ester Carballo‐Jane, (unknown), Silvi Luell, John Woods, Emanuel Zycband, M. Gerard Waters, M J Forrest	6
8	Cyclopentane-based human NK1 antagonists. Part 2: Development of potent, orally active, water-soluble derivatives 2006 ·Bioorganic & Medicinal Chemistry Letters ·Laura C. Meurer, Paul E. Finke, Karen Owens, Nancy N. Tsou, Richard G. Ball, Sander G. Mills, Malcolm MacCoss, Sharon Sadowski, Margaret A. Cascieri, Kwei‐Lan Tsao, Gary G. Chicchi, Linda A. Egger, Silvi Luell, Joseph M. Metzger, D. Euan MacIntyre, N.M.J. Rupniak, Angela Williams, Richard Hargreaves	21
9	Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Shrenik K. Shah, Stephen G Pacholok, John L. Humes, Richard A. Mumford, Stephan K. Grant, Renee M. Chabin, Barbara G. Green, Nancy N. Tsou, Richard Ball, Daniel S. Fletcher, Silvi Luell, D. Euan MacIntyre, Malcolm MacCoss	17
10	Skeletal muscle: a dual system to measure glucocorticoid-dependent transactivation and transrepression of gene regulation 2004 ·The Journal of Steroid Biochemistry and Molecular Biology ·Ester Carballo‐Jane, Shilpa Pandit, Joseph C. Santoro, (unknown), Silvi Luell, Georgianna Harris, Michael J. Forrest, Ayesha Sitlani	27
11	Beta-3 Adrenergic Receptor Agonists Cause an Increase in Gastrointestinal Transit Time in Wild-type Mice, But Not in Mice Lacking the Beta-3 Adrenergic Receptor 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Daniel S. Fletcher, Mari R. Candelore, Danica Grujić, Bradford B. Lowell, Silvi Luell, Vedrana S. Susulic, D. Euan MacIntyre	22
12	Therapeutic Administration of a Selective Inhibitor of Nitric Oxide Synthase Does Not Ameliorate the Chronic Inflammation and Tissue Damage Associated with Adjuvant-Induced Arthritis in Rats 1998 ·Journal of Pharmacology and Experimental Therapeutics ·D. Fletcher, William R. Widmer, Silvi Luell, Anna Christen, (unknown), (unknown), Denise M. Visco	79
13	3-Benzyloxy-2-phenylpiperidine NK1 antagonists: the influence of alpha methyl substitution 1997 ·Bioorganic & Medicinal Chemistry Letters ·Christopher J. Swain, Brian J. Williams, R. BAKER, Margaret A. Cascieri, Gary G. Chicchi, (unknown), Richard H. Herbert, Linda E. Keown, T. Ladduwahetty, Silvi Luell, D. Euan MacIntyre, Joseph M. Metzger, S. Morton, Andrew P. Owens, Sharon Sadowski, Alan P. Watt	14
14	A Synthetic Inhibitor of Interleukin-lβ Converting Enzyme Prevents Endotoxin-Induced Interleukin-lβ Production In Vitro and In Vivo 1995 ·Journal of Interferon & Cytokine Research ·D. Fletcher, (unknown), (unknown), Jayne Chin, Linda A. Egger, G Limjuco, Silvi Luell, D. Euan MacIntyre, Erin P. Peterson, Nancy A. Thornberry, Matthew J. Kostura	35
15	MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor. 1993 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Silvi Luell, (unknown), (unknown), (unknown), (unknown)	5
16	Synthesis and biological activity of MK 287 (L-680,573): a potent, specific and orally active paf receptor antagonist 1991 ·Bioorganic & Medicinal Chemistry Letters ·Soumya P. Sahoo, Donald W. Graham, John J. Acton, Tesfaye Biftu, Robert L. Bugianesi, N. N. Girotra, (unknown), Mitree M. Ponpipom, Thomas W. Doebber, Margaret Wu, San-Bao Hwang, My‐Hanh Lam, D. Euan MacIntyre, Thomas J. Bach, Silvi Luell, Roger Meurer, Philip R. Davies, Alfred W. Alberts, John C. Chabala	13
17	2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesis 1989 ·Journal of Medicinal Chemistry ·Milton L. Hammond, Ihor E. Kopka, Robert A. Zambias, Charles G. Caldwell, Joshua Boger, (unknown), (unknown), Silvi Luell, D. Euan MacIntyre	31
18	Pharmacological modulation of eicosanoid levels and hyperalgesia in yeast-induced inflammation 1987 ·Biochemical Pharmacology ·Evan E. Opas, Aimée Dallob, (unknown), Silvi Luell, John L. Humes	23
19	Mouse Leukæmias: Genetic Determination of the TL (Thymus–leukæmia) Antigen in the Mouse 1964 ·Nature ·Edward A. Boyse, Lloyd J. Old, Silvi Luell	54
20	Antigenic Properties of Experimental Leukemias. II. Immunological Studies <italic>In Vivo</italic> With C57BL/6 Radiation-Induced Leukemias<xref ref-type="fn" rid="FN2">2</xref> 1963 ·JNCI Journal of the National Cancer Institute ·Edward A. Boyse, Lloyd J. Old, Silvi Luell	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact